Clinical Trial Update: Special Access Program IMVAMUNE® [Phase 4]

View source ↗

Summary

Phase 4 Special Access Program update for IMVAMUNE, with completed status and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Vaccination

Drugs mentioned

• IMVAMUNE (Modified Vaccinia Ankara (MVA))

Snippet

Sponsor: Bavarian Nordic | Conditions: Vaccination | Phase 4 | Status: COMPLETED | Results posted: 2020-08-19